The tennis pro is teaming up with the medical device giant to launch a global campaign aimed at inspiring people living with ...

Medtronic's MiniMed 670G - the closest thing yet to an artificial pancreas - has been launched in the US. The so-called 'hybrid closed-loop' system comprises a blood glucose sensor, the MiniMed ...

The diabetes conference featured a debate about over-the-counter glucose monitors and updates on upcoming devices, including ...

Pregnant women with type 1 diabetes who used hybrid closed-loop insulin delivery with Control-IQ technology spent more time ...

Shares of Dexcom, Tandem Diabetes and Insulet skidded Tuesday on a proposal that would cut Medicare reimbursements for ...

The agency overseeing Medicare and Medicaid proposes $4.5 billion of spending cuts for home healthcare, and new economies on ...

NovoLog (insulin aspart) is a fast-acting insulin used for diabetes treatment. It’s injected 5 to 10 minutes before meals. It may be prescribed with other insulins or oral diabetes drugs.

By the Journal Star editorial board Jul 6, 2013 Updated Jan 28, 2015 0 ...

The global continuous glucose monitoring device market is estimated to be valued at USD 12,690.7 million in 2025 and is projected to reach USD 54,553.1 million by 2035, registering a CAGR of 15.7% ...

Regular physical activity is important for managing type 2 diabetes. Exercises like walking, swimming, and yoga can contribute to better blood sugar management. Regular exercise and physical ...

The Dow Jones Industrial Average rose on Tuesday as investors rotated out of technology stocks to kick off the second half of ...

AstraZeneca has revealed plans to set up a new strategic R&D hub in Cambridge, Massachusetts as it reported a massive increase in first-quarter revenues, driven by COVID-19 and oncology drugs and ...